11th Jul 2024 16:42
Graft Polymer (UK) PLC - London-based developer and producer of alloyed polymers, biological supplements and drug delivery systems - Files US patent applications for the treatment of substance abuse disorders and mental health disorders using depot drug delivery systems. Graft Polymer says the patent applications aim to leverage its biopolymer expertise in mental health therapy and the treatment of addiction. It is seeking to develop its intellectual property portfolio as part of its new focus on the healthcare industry following the disposal of its industrial plastic manufacturing unit, Graft Polymer DOO. Read More